1. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020; 395:470–3.
2. Kim JY, Choe PG, Oh Y, Oh KJ, Kim J, Park SJ, et al. The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures. J Korean Med Sci. 2020; 35:e61.
7. Park IN, Yum HK. Stepwise strategy of social distancing in Korea. J Korean Med Sci. 2020; 35:e264.
9. Yenhap News. Cheongju City's 'quarantine 15’ remarks to subordinate employees and demands disciplinary action against Grade 6 employees [Internet]. Seoul (Korea): Yenhap News;2020. [cited 2020 August 28]. Available from:
https://www.yna.co.kr/view/AKR20200723062000064.
10. Kim JH, Yun S, Hwang SS, Shim JO, Chae HW, Lee YJ, et al. The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects. Korean J Pediatr. 2018; 61:135–49.
11. Telford RM, Telford RD, Olive LS, Cochrane T, Davey R. Why are girls less physically active than boys? Findings from the LOOK Longitudinal Study. PLoS One. 2016; 11:e0150041.
12. de Groot CJ, van den Berg A, Ballieux BEPB, Kroon HM, Rings EHHM, Wit JM, et al. Determinants of advanced bone age in childhood obesity. Horm Res Paediatr. 2017; 87:254–63.
13. Ahmed ML, Ong KK, Dunger DB. Childhood obesity and the timing of puberty. Trends Endocrinol Metab. 2009; 20:237–42.
14. Papadimitriou A, Nicolaidou P, Fretzayas A, Chrousos GP. Clinical review: constitutional advancement of growth, a.k.a. early growth acceleration, predicts early puberty and childhood obesity. J Clin Endocrinol Metab. 2010; 95:4535–41.
15. Yoon JW, Park HA, Lee J, Kim JH. The influence of gonadotropin - releasing hormone agonists on anthropometric change in girls with central precocious puberty. Korean J Pediatr. 2017; 60:395–402.
16. Arrigo T, De Luca F, Antoniazzi F, Galluzzi F, Segni M, Rosano M, et al. Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty. Eur J Endocrinol. 2004; 150:533–7.
17. Park J, Kim JH. Change in body mass index and insulin resistance after 1-year treatment with gonadotropin-releasing hormone agonists in girls with central precocious puberty. Ann Pediatr Endocrinol Metab. 2017; 22:27–35.
18. Kim SW, Kim YB, Lee JE, Kim NR, Lee WK, Ku JK, et al. The influence of gonadotropin releasing hormone agonist treatment on the body weight and body mass index in girls with idiopathic precocious puberty and early puberty. Ann Pediatr Endocrinol Metab. 2017; 22:95–101.
19. Tadic M, Cuspidi C, Sala C. COVID-19 and diabetes: Is there enough evidence? J Clin Hypertens (Greenwich). 2020; 22:943–8.
20. Zhu L, She ZG, Cheng X, Qin JJ, Zhang XJ, Cai J, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020; 31:1068–77. e3.
21. Khoo B, Tan T, Clarke SA, Mills EG, Patel B, Modi M, et al. Thyroid function before, during, and after COVID-19. J Clin Endocrinol Metab. 2021; 106:e803–11.
22. Ceconi V, Barbi E, Tornese G. Glycemic control in type 1 diabetes mellitus and COVID-19 lockdown: what comes after a "quarantine"? J Diabetes. 2020; 12:946–8.
23. Tittel SR, Rosenbauer J, Kamrath C, Ziegler J, Reschke F, Hammersen J, et al. Did the COVID-19 Lockdown affect the incidence of pediatric type 1 diabetes in Germany? Diabetes Care. 2020; 43:e172–3.
24. Park J, Hwang TH, Kim YD, Han HS. Longitudinal follow-up to near final height of auxological changes in girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analog and grouped by pretreatment body mass index level. Ann Pediatr Endocrinol Metab. 2018; 23:14–20.